Jane Wasman

Insider Reports History

Location
Ardsley, NY
Signature
/s/ Jane Wasman
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jane Wasman:

Stock Role Class Num Shares Value Price $ Report Date Ownership
RIGEL PHARMACEUTICALS INC Director Common Stock 12.5K $238K $19.06 23 May 2025 Direct
SELLAS Life Sciences Group, Inc. Director Common Stock 30.4K $51.4K $1.69 30 May 2025 Direct
ATHERSYS, INC / NEW Director Common Stock 35.1K $879 $0.03 09 Jan 2023 Direct
SELLAS Life Sciences Group, Inc. Director Stock Option (Right to Buy) 18.5K 10 Jan 2025 Direct
RIGEL PHARMACEUTICALS INC Director Stock Option (Right to Buy) 3K 23 May 2025 Direct

Insider Reports Filed by Jane Wasman

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SLS SELLAS Life Sciences Group, Inc. 30 May 2025 1 $33.8K 4 Director 02 Jun 2025, 16:42
RIGL RIGEL PHARMACEUTICALS INC 23 May 2025 2 $0 4 Director 28 May 2025, 17:27
SLS SELLAS Life Sciences Group, Inc. 10 Jan 2025 2 $0 4 Director 14 Jan 2025, 17:33
RIGL RIGEL PHARMACEUTICALS INC 25 May 2024 2 $0 4 Director 29 May 2024, 19:21
SLS SELLAS Life Sciences Group, Inc. 22 Jan 2024 2 $0 4 Director 25 Jan 2024, 06:02
RIGL RIGEL PHARMACEUTICALS INC 26 May 2023 2 $0 4 Director 12 Jul 2023, 18:45
SLS SELLAS Life Sciences Group, Inc. 02 Feb 2023 2 $0 4 Director 03 Feb 2023, 16:13
ATHX ATHERSYS, INC / NEW 09 Jan 2023 1 $0 4 Director 11 Jan 2023, 11:30
ATHX ATHERSYS, INC / NEW 16 Sep 2022 2 $0 4 Director 20 Sep 2022, 13:39
RIGL RIGEL PHARMACEUTICALS INC 20 May 2022 2 $0 4 Director 23 May 2022, 17:50
SLS SELLAS Life Sciences Group, Inc. 31 Jan 2022 2 $0 4 Director 01 Feb 2022, 16:07
ATHX ATHERSYS, INC / NEW 15 Jun 2021 1 $0 4 Director 15 Jun 2021, 17:39
RIGL RIGEL PHARMACEUTICALS INC 19 May 2021 2 $0 4 Director 21 May 2021, 21:03